Insider · CIK 0001768217
Balkrishan Kalra
Files at G (Genpact LTD). First filing Nov 26, 2024, latest Sep 16, 2026.
In brief
Balkrishan Kalra files SEC Form 4 as CEO, president and director at G (Genpact LTD). Since Nov 26, 2024, Balkrishan Kalra has reported 0 open-market buys worth $0 and 6 open-market sells worth $4.6M, the latest filed on Sep 16, 2026.
A track record needs three past buys with six months of prices behind them; Balkrishan Kalra has 0, so none is measured yet.
The newest scored trade: sold $368k of G on Sep 14, 2026, filed Sep 16, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $482k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
G: Genpact LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Gsell Genpact LTD | $368k 10,000 shares | -2% | - | |
| 20Weak | Gsell Genpact LTD | $114k 2,800 shares | -1% | +12% from low-21% from high | |
| 55Moderate | Genpact LTD | $2.4M 55,000 shares | -18% | +15% from low-21% from high | |
| 10Weak | Genpact LTD | $665k 13,600 shares | -4% | - | |
| 9Weak | Genpact LTD | $607k 13,600 shares | -5% | - | |
| 56Moderate | Genpact LTD | $418k 9,000 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 14, 2026 | G GENPACT LIMITED | 10,000 0.01% of outstanding | $368k | Sep 14, 2026 | none |
| Mar 4, 2026 | G GENPACT LIMITED | 2,800 0.00% of outstanding | $114k | Mar 4, 2026 | none |
| Sep 11, 2025 | G GENPACT LIMITED | 55,000 0.03% of outstanding | $2.4M | Sep 11, 2025 | none |
| Mar 13, 2025 | G GENPACT LIMITED | 13,600 0.01% of outstanding | $665k | Mar 13, 2025 | none |
| Dec 13, 2024 | G GENPACT LIMITED | 13,600 0.01% of outstanding | $607k | Dec 13, 2024 | $418k |
| Nov 25, 2024 | G Genpact LTD | 9,000 0.01% of outstanding | $418k | Nov 25, 2024 | $270k |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | G Genpact LTD | SOpen-market sale Common Shares | -10,000 | $36.79 | $368k | 501,114 | 27 d ago |
| Mar 10, 2026 | G Genpact LTD | FTax withholding Common Shares | -13,893 | $38.92 | $541k | 511,114 | Mar 12, 2026 |
| Mar 3, 2026 | G Genpact LTD | AGrant or award Common Shares | +27,160 | $0.00 | $0 | 525,007 | Mar 5, 2026 |
| Mar 4, 2026 | G Genpact LTD | MOption exercise Common Shares | +2,800 | $27.65 | $77k | 527,807 | Mar 5, 2026 |
| Mar 4, 2026 | G Genpact LTD | SOpen-market sale Common Shares | -2,800 | $40.77 | $114k | 525,007 | Mar 5, 2026 |
| Mar 4, 2026 | G Genpact LTD | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,800 | $0.00 | $0 | 0 | Mar 5, 2026 |
| Jan 30, 2026 | G Genpact LTD | AGrant or award Common Shares | +106,575 | $0.00 | $0 | 497,260 | Feb 3, 2026 |
| Jan 10, 2026 | G Genpact LTD | FTax withholding Common Shares | -29,691 | $48.24 | $1.4M | 390,685 | Jan 13, 2026 |
| Dec 17, 2025 | G Genpact LTD | AGrant or award Common Shares | +125,130 | $0.00 | $0 | 420,376 | Dec 19, 2025 |
| Sep 11, 2025 | G Genpact LTD | SOpen-market sale Common Shares | -15,000 | $43.39 | $651k | 295,246 | Sep 15, 2025 |
| Sep 11, 2025 | G Genpact LTD | MOption exercise Common Shares | +40,000 | $27.65 | $1.1M | 335,246 | Sep 15, 2025 |
| Sep 11, 2025 | G Genpact LTD | SOpen-market sale Common Shares | -40,000 | $43.35 | $1.7M | 295,246 | Sep 15, 2025 |
| Sep 11, 2025 | G Genpact LTD | MOption exercise Employee Stock Option (Right to Buy)derivative | -40,000 | $0.00 | $0 | 2,800 | Sep 15, 2025 |
| Mar 13, 2025 | G Genpact LTD | MOption exercise Common Shares10b5-1 | +13,600 | $27.65 | $376k | 323,846 | Mar 14, 2025 |
| Mar 13, 2025 | G Genpact LTD | SOpen-market sale Common Shares10b5-1 | -13,600 | $48.89 | $665k | 310,246 | Mar 14, 2025 |
| Mar 13, 2025 | G Genpact LTD | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -13,600 | $0.00 | $0 | 42,800 | Mar 14, 2025 |
| Mar 11, 2025 | G Genpact LTD | AGrant or award Common Shares | +78,782 | $0.00 | $0 | 310,246 | Mar 13, 2025 |
| Jan 10, 2025 | G Genpact LTD | FTax withholding Common Shares | -36,461 | $43.34 | $1.6M | 230,943 | Jan 14, 2025 |
| Dec 13, 2024 | G Genpact LTD | MOption exercise Common Shares10b5-1 | +13,600 | $27.65 | $376k | 281,004 | Dec 17, 2024 |
| Dec 13, 2024 | G Genpact LTD | SOpen-market sale Common Shares10b5-1 | -13,600 | $44.60 | $607k | 267,404 | Dec 17, 2024 |
| Dec 13, 2024 | G Genpact LTD | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -13,600 | $0.00 | $0 | 56,400 | Dec 17, 2024 |
| Nov 25, 2024 | G Genpact LTD | SOpen-market sale Common Shares | -9,000 | $46.40 | $418k | 267,404 | Nov 26, 2024 |
| Mar 13, 2024 | G Genpact LTD | AGrant or award Common Shares | +96,848 | $0.00 | $0 | 283,404 | Mar 15, 2024 |
| Jan 10, 2024 | G Genpact LTD | FTax withholding Common Shares | -25,531 | $34.27 | $875k | 185,837 | Jan 12, 2024 |
Questions about Balkrishan Kalra
Answered from the filings on this page, as of the latest one.
Is Balkrishan Kalra buying or selling?
In the last 12 months Balkrishan Kalra reported 0 open-market buys worth $0 and 2 open-market sells worth $482k on SEC Form 4; the latest was sold $368k of G on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Balkrishan Kalra's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Balkrishan Kalra has 0.
Where does Balkrishan Kalra file Form 4?
Balkrishan Kalra has filed Form 4 at G (Genpact LTD) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.